Bayer sets up oxygen plant at Guwahati medical college

Guwahati: A medical-grade oxygen plant with 500 LPM (litres of oxygen per minute) capacity, set up at the Cardiothoracic and Neuroscience Centre, Gauhati Medical College and Hospital, was dedicated to the people of Assam on Wednesday.

The state's Health and Family Welfare minister Keshab Mahanta was present on the occasion.
Bayer, a global enterprise with core competencies in the life science fields of healthcare and agriculture, has set up the oxygen plant at the hospital, in partnership with LabourNet as part of its CSR initiative.
GMCH is the largest tertiary care hospital with 2500 beds, catering to a population of over ten lakh people in Guwahati and patients from neighbouring districts.
"The plant will provide an adequate oxygen supply to meet the hospital's demand, enabling it to provide high-quality healthcare services to the community," a release stated on Wednesday.
When operated for 8 hours a day, the plant can produce 202,500 litres of oxygen in a year, equivalent to 1,800 oxygen cylinders.
"The government's aim is to provide affordable healthcare to every citizen of Assam and is equipping state-run hospitals with modern critical equipment like oxygen plants to meet any future eventuality," said Mahanta.
Speaking on the launch, Rachana Panda, vice-president, and country head, Communications, Public Affairs, Sustainability and CSE, Bayer South Asia, said, "Bayer has a long-standing reputation as a healthcare pioneer and is collaborating closely with multiple partners to enhance the public health infrastructure of the country. As part of this endeavour, we are delighted to support the Assam government's efforts to establish essential health infrastructure such as oxygen plants in public hospitals. The oxygen plant will also contribute to achieving the government's objective of providing cost-effective and high-quality healthcare in rural and underserved areas."
Apart from GMCH in Assam, Bayer has also set up oxygen plants in the Sambalpur district of Odisha, Raichur district of Karnataka, and Tikamgarh in Madhya Pradesh. 


from Medical News, Health News Latest, Medical News Today - Medical Dialogues | https://ift.tt/AarmoQ5

Comments

Post a Comment

Popular posts from this blog

'Details sought include Third-party info, hence exempted under RTI Act': NMC on RTI query on Faculty Gap in Medical Colleges

Image
New Delhi:  Stating that the details sought under the RTI includes third-party information, the National Medical Commission (NMC) has refused to disclose the names of the medical colleges that fell short on faculty counts and other teaching infrastructure. Recently activist Dr. KV Babu filed an application under the Right to Information Act seeking the details of the notices issued by the NMC Undergraduate Medical Education Board (UGMEB) to the medical colleges for deficiencies in Clinical Material and staff during the period from 01/01/2023 to 30/04/2024. He also sought to know the details of the fine imposed or the action taken by the NMC UG Board from 01/01/2023 to 30/04/2024. In response, the Apex medical regulatory body in India has said that the concerned information includes third party information. "Since the information sought by you, includes third party information, hence the same is exempted for as per Section 8(1) (j) of the Right to Information Act, 2005," th...
Read more

Zasocitinib therapy highly efficacious for treatment of severe plaque psoriasis: JAMA

Image
A recent study published in the Journal of American Medical Association revealed that Zasocitinib could be a breakthrough in the treatment of moderate to severe plaque psoriasis. Psoriasis is a chronic inflammatory skin condition characterized by red, scaly patches, affects millions throughout the globe. While several treatments exist, the demand for new, effective, and well-tolerated oral therapies remains high. Zasocitinib, a highly selective allosteric tyrosine kinase 2 (TYK2) inhibitor, emerges as a promising candidate to meet this need. This trial was conducted between August 2021 and September 2022 across 55 centers in the US and Canada and found that Zasocitinib not only significantly improved skin clearance in patients but also expressed a favorable safety and tolerability profile. The study enrolled a total of 287 participants aged between 18 and 70 years, each with a Psoriasis Area and Severity Index (PASI) score of 12 or greater, a Physician’s Global Assessment score of 3...
Read more

New wearable laser device may monitor brain blood flow to gauge stroke risk, reports research

Image
Researchers have developed a laser-based device that can be placed on the head to non-invasively monitor changes in brain blood flow and volume. The new device could one day help save lives by offering a direct and simple way to assess stroke risk based on physiological markers rather than indirect markers like lifestyle factors. Strokes occur when blood flow to the brain is blocked or reduced, causing debilitating brain cell damage. With about 15 million people worldwide affected by strokes each year, it is the second leading cause of death and a leading cause of long-term disability. “The lack of a cost-effective and scalable stroke risk assessment system complicates long-term stroke prevention because a physician can’t tell whether a patient’s risk is stable or worsening,” said research team member Simon Mahler, a postdoctoral scholar in Changhuei Yang’s laboratory at the California Institute of Technology. “This new method could help catch early signs of increased stroke risk, w...
Read more